Search

everythinglearnresearchcommunity

for

Search:↓

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

All types of Platelet-Rich Plasma (PRP) can treat hair loss, but homologous PRP works best due to its higher platelet count and growth factors from multiple donors.

MAFT is a reliable method for forehead contouring with high patient satisfaction and long-term results.

Gilles de la Tourette syndrome is treatable, with behavioral therapy as a recommended first option and other treatments available for more severe cases.

Erbium glass laser treatment may help with skin remodeling, reduce inflammation, and improve skin cell maturation.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

A rare skin rash after COVID-19 vaccination shouldn't stop future vaccinations.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Aromatic plants can naturally help prevent skin aging and improve skin health.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

HPV vaccines are generally safe but need further investigation for rare side effects.

Testicular microlithiasis may increase the risk of testicular cancer and patients with it should be closely monitored.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Dupilumab helps children with alopecia areata regrow hair safely.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Obesity increases the risk of skin infections, inflammatory conditions, and melanoma, but not basal cell carcinoma.

NGAL may help maintain skin balance and is linked to skin disorders and cancers.

People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

PSU are better than THF at regenerating skin layers in lab models.

Some chemicals absorbed through the skin can cause serious health problems.

Hair casts and cutaneous spicules can be signs of multiple myeloma.

Leucaena leucocephala is nutritious but needs careful processing to remove toxins.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Finasteride exposure harms tadpole reproduction and hormone balance.